The pharmaceutical world is seeing a major shift in glucose management with the arrival of GLP-1 transdermal devices. These patches offer a seemingly more comfortable alternative to injections of GLP-1 drugs, lessening the need for daily needle pokes. The innovation releases the compound directly through the epidermis, potentially boosting perso… Read More